Search Results - "Galstyan, R."

The use of long-acting insulin degludec in adult patients with type 2 diabetes mellitus in real clinical practice in Russia by Galstyan, G. R.

“…BACKGROUND: Effective glycaemic control remains the most important task in managing the risks of Diabetes type 2 complications development. In this regard, the…”
Get full text

ATOS study: effectiveness and safety of insulin glargine 300 U/mL in the real world clinical practice in insulin-naïve type 2 diabetic patients in the Russian Federation by Galstyan, Gagik R.

“…Rationale: Basal insulin glargine 300 U/mL (Gla-300) is a second-generation basal insulin analogue that has comparable efficacy and lower variability compared…”
Get full text

The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study) by Dedov, Ivan I., Shestakova, Marina V., Galstyan, Gagik R.

“…Aim. To estimate the prevalence of type 2 diabetes mellitus (T2DM) in Russian adults.Materials and methods. NATION was a national, epidemiological,…”
Get full text

Effects of GLP-1RAs on cardiovascular outcomes in patients with type 2 diabetes mellitus: review of real-world data on target populations from diabetes registry in Russian Federation by Vikulova, O. K., Galstyan, G. R., Shestakova, M. V.

“…RATIONALE. Over the past 20 years the prevalence of type 2 diabetes in Russia has more than doubled and reached 4.43 million people in 2020, while the growth…”
Get full text

Comparative analysis of traditional power supply and operation of solar panels in protected ground systems by Antonov, M A, Kaun, O Y, Yurov, A A, Galstyan, R A, Abramov, Y V

“…This article discusses the issues of autonomous power supply of the greenhouse. The types of greenhouses and their main microclimate parameters are considered…”
Get full text

Humoral factors in the formation of neuroosteoarthropathy in type 2 diabetes mellitus by Kalandiya, M. M., Kogan, E. A., Nikankina, L. V., Tokmakova, A. Y., Zaitseva, E. L., Galstyan, G. R.

“…B ACKGROUND : Diabetic neuroosteoarthropathy is a severe and insufficiently studied complication of diabetes mellitus, which is characterized by progressive…”
Get full text

Long-term results of corrective surgical interventions in patients with diabetic midfoot neuroosteoarthropathy by Kalandiya, M. M., Doronina, L. P., Mitish, V. A., Tokmakova, A. Yu, Zaitseva, E. L., Galstyan, G. R.

“…BACKGROUND : Diabetic neuroosteoarthropathy is a disabling complication of diabetes mellitus that develops as a result of impaired peripheral innervation and…”
Get full text

Clinical evaluation of the implementation of the first pilot Russian integrated program for an integrated approach to the management of diabetes mellitus “NORMA” by Galstyan, G. R., Mayorov, A. Y., Melnikova, O. G., Holmskaya, N. I., Hamradjanov, Z. A., Milyutin, V. I., Shestakova, M. V.

“…BACKGROUND : Despite progress in the treatment of patients with diabetes mellitus (DM), the problem of achieving target values of glycemic control remains…”
Get full text

The role of neurohumoral factors in the persistence of aseptic bone inflammation in patients with diabetic neuroosteoarthropathy by Zaitseva, E. L., Kalandiya, M. M., Tokmakova, A. Yu, Malysheva, N. M., Nikankina, L. V., Galstyan, G. R.

“…BACKGROUND : Diabetic neuroosteoarthropathy (DNOAP, Charcot foot) is a relatively rare complication of diabetes mellitus (DM), which can lead not only to…”
Get full text

National Council of Experts: the place of DPP-4 inhibitors in the treatment of patients with type 2 diabetes mellitus by Shestakova, M. V., Vagapova, G. R., Vikulova, O. K., Galstyan, G. R., Demidova, T. Yu, Dudinskaya, E. N., Kiseleva, T. P., Mkrtumyan, A. M., Petunina, N. A., Tkacheva, O. N., Fadeev, V. V., Khalimov, Y. S., Shestakova, E. A.

“…TThe annual increase in the prevalence of type 2 diabetes mellitus emphasizes the relevance of the search for new treatment options, along with necessity for…”
Get full text

Insufficiency/deficiency of vitamin B12 in patients in the endocrinological practice by Mokrysheva, N. G., Shestakova, M. V., Ametov, A. S., Antsiferov, M. B., Bakulin, I. G., Vavilova, T. V., Galstyan, G. R., Demidova, T. Y., Dzgoeva, F. K., Karonova, T. L., Lukina, E. A., Mkrtumyan, A. M., Petunina, N. A., Ponomaryov, R. V., Suponeva, N. A., Sukhareva, O. Y., Shamkhalova, M. S.

“…On March 20, 2024, an interdisciplinary meeting of the Expert Council on the current problem of B12 insufficiency/deficiency and the prevalence of this…”
Get full text

The role of canagliflozin in the prevention of stroke and chronic kidney disease in patients with type 2 diabetes mellitus: an expert council resolution by Shestakova, M. V., Galstyan, G. R., Grineva, E. N., Zilov, A. V., Demidova, T. Yu, Mkrtumyan, A. M., Petunina, N. A., Ruyatkina, L. A., Sukhareva, O. Y., Suplotova, L. A., Shamkhalova, M. S.

“…Over the past 10 years of studying the complications of type 2 diabetes mellitus (DM) and ways to deal with them, significant progress has been made in one of…”
Get full text

Comprehensive assessment of cardiovascular complications in a patient with type 1 diabetes mellitus, chronic kidney disease and diabetic neuroosteoarthropathy by Bondarenko, Olga N., Yaroslavceva, Marianna V., Tokmakova, Alla Y., Galstyan, Gagik R., Tarbaeva, Natalia V.

“…The paper presents a clinical case of the patient with long-term poor control of type 1 diabetes mellitus, chronic kidney disease (CKD) and diabetic…”
Get full text

Pancreatic exocrine insufficiency in diabetes mellitus by Shestakova, M. V., Maev, I. V., Ametov, A. S., Antsiferov, M. B., Bordin, D. S., Galstyan, G. R., Dzgoeva, F. K., Kucheryavyy, Y. A., Mkrtumyan, A. M., Nikonova, T. V., Pashkova, E. Y.

“…Diabetes is disease of both the endo- and exocrine parts of the pancreas. Pancreatic exocrine insufficiency (PEI) can occur in every 2–3 patients with diabetes…”
Get full text

Prospects of finerenone use in Russian population of patients with chronic kidney disease and type 2 diabetes. Resolution of multidisciplinary. Advisory board by Shestakova, M. V., Dobronravov, V. A., Ametov, A. S., Antsiferov, M. B., Batyushin, M. M., Bobkova, I. N., Galstyan, G. R., Demidova, T. Y., Klimontov, V. V., Mkrtumyan, A. M., Petunina, N. A., Prokopenko, E. I., Chebotareva, N. V., Shamkhalova, M. S.

“…Chronic kidney disease (CKD) in patients with type 2 diabetes (T2D) is one of the most important medical and social problems associated with significant risks…”
Get full text

Long-term Follow-up of treatment of chronic foot wounds with recombinant human epidermal growth factor in patients with different complications of diabetes mellitus by Zaitseva, E. L., Zhilyaev, V. M., Galstyan, G. R.

“…BACKGROUND : Diabetic foot ulcer (DFU) is a dangerous complication of diabetes mellitus (DM), which can lead to the development of chronic wounds and…”
Get full text

The advisory board resolution on the use of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes by Antsiferov, M. B., Galstyan, G. R., Demidova, T. Yu, Zilov, A. V., Markova, T. N., Mkrtumyan, А. M., Petunina, N. A., Khalimov, I. S., Shamkhalova, M. S., Shestakova, M. V.

“…Type 2 diabetes is characterized by increasing incidence and prevalence all-over the world. Current therapeutic management of type 2 diabetes is complex and is…”
Get full text

Immunohistochemical features of the bone tissue of the lower extremities in patients with type 2 diabetes mellitus by Tokmakova, A. Yu, Kogan, E. A., Zaitseva, E. L., Demura, S. A., Zharkov, N. V., Kalandiya, M. M., Galstyan, G. R.

“…Background : Diabetic neuroosteoarthropathy is a serious disabling complication of diabetes mellitus, which, in the absence of timely correct treatment, can…”
Get full text

Oral semaglutide: the innovation in type 2 diabetes management by Shestakova, M. V., Shamkhalova, M. Sh, Galstyan, G. R., Ruyatkina, L. A., Suplotova, L. A.

“…Oral semaglutide is the first-in-class glucagon-like peptide-1 receptor agonist available in the form of pills administered per os. PIONEER — the clinical…”
Get full text

The Scientific Advisory board resolution: Implementation of intermittently scanned Continuous Glucose monitoring in clinical practice to improve glycemic control by Peterkova, V. A., Ametov, A. S., Mayorov, A. Y., Galstyan, G. R., Laptev, D. N., Chernikova, N. A.

“…The Scientific Advisory Board chaired by Academician of the Russian Academy of Sciences, Peterkova V.A. was held 26 of November in Moscow to discuss the…”
Get full text